Free Trial

CannaPharmaRX Q2 2024 Earnings Report

CannaPharmaRX logo
$0.0078 0.00 (-13.33%)
(As of 12/20/2024 05:55 PM ET)

CannaPharmaRX Earnings Headlines

PSIQ Profile Solutions, Inc.
Vladimir Lenin was right…
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.
CannaPharmaRX, Inc. (CPMD)
CannaPharmaRx to Host Investor Conference Call
See More CannaPharmaRX Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like CannaPharmaRX? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CannaPharmaRX and other key companies, straight to your email.

About CannaPharmaRX

CannaPharmaRX (OTCMKTS:CPMD) operates in the cannabis industry in Canada. It evaluates, negotiates, acquires, and develops various cannabis cultivation projects. The company was incorporated in 1998 and is based in Calgary, Canada.

View CannaPharmaRX Profile

More Earnings Resources from MarketBeat

Upcoming Earnings